Monday, July 15, 2019

Home » » GSK drug helps ovarian cancer patients live longer in late-stage study

GSK drug helps ovarian cancer patients live longer in late-stage study

No comments
GlaxoSmithKline Plc's cancer treatment Zejula met the main goal of helping patients with ovarian cancer live longer without their disease worsening in a late-stage study, the company said on Monday.


from Reuters: Health News https://ift.tt/2xLOUGl
via IFTTT
Share:  Facebook Twitter Google+

0 comments:

Post a Comment